EP2567690
Notkun á amísúlfríði við meðferð á ógleði og uppköstum eftir efnameðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.3.2011EP published:
16.7.2014EP application number:
12188047.0
EP translation filed:
6.8.2014Grant published:
15.8.2014EPO information:
European Patent Register
Max expiry date:
9.3.2031Expiry date:
9.3.2026Next due date:
31.3.2026
Title:
Use of amisulpride for treating chemotherapy-induced nausea and vomiting
Timeline
Owner
Name:
Acacia Pharma LimitedAddress:
Harston Mill, Harston, Cambridgeshire CB22 7GG, GB
Inventor
Name:
Gilbert, Julian CliveAddress:
Harston, Cambridgeshire GB22 7GG, GB
Name:
Gristwood, Robert WilliamAddress:
Whittlesford, Cambridgeshire CB22 4PL, GB
Name:
Cooper, NicolaAddress:
Ashdon, Essex CB10 2JE, GB
Name:
Fox, GabrielAddress:
Harston, Cambridgeshire CB22 7GG, GB
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201004020Date:
11.3.2010Country:
GB
Classification
Categories:
A61K 9/00, A61K 31/40, A61K 31/485, A61K 31/282, A61K 47/12, A61P 1/08, A61K 31/4178
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.3.2015
Expires: 9.3.2016
Payer: Guðjón Styrkársson, hrl.
Number: 6
Paid: 21.3.2016
Expires: 9.3.2017
Payer: Guðjón Styrkársson, hrl.
Number: 7
Paid: 20.3.2017
Expires: 9.3.2018
Payer: Guðjón Styrkársson, hrl.
Number: 8
Paid: 19.3.2018
Expires: 9.3.2019
Payer: Guðjón Styrkársson, hrl.
Number: 9
Paid: 18.3.2019
Expires: 9.3.2020
Payer: Guðjón Styrkársson, hrl.
Number: 10
Paid: 19.3.2020
Expires: 9.3.2021
Payer: Patice ehf.
Number: 11
Paid: 22.3.2021
Expires: 9.3.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 21.3.2022
Expires: 9.3.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 26.3.2023
Expires: 9.3.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 28.2.2024
Expires: 9.3.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 11.2.2025
Expires: 9.3.2026
Payer: Árnason Faktor ehf.